Oblon Spivak's Arthur Neustadt Quoted in Law360 Regarding the Federal Circuit's Decision in Medtronic IP Case

September 18, 2012 – In The News
Law360, New York (September 18, 2012)

Oblon Spivak's Arthur Neustadt is quoted in the recent Law360 article regarding the Federal Circuit's decision in the Medtronic IP case. The Federal Circuit overturned a lower court's ruling that Boston Scientific had the burden of proof. Mr. Neustadt said his client welcomed the ruling. "We've said all along that we didn't have the burden of proof, and we're pleased we were able to convince the Federal Circuit. As the declaratory judgment plaintiff, Medtronic was the only party seeking relief, so it was "only logical" that it be found to have the burden of proof."

Mirowski licenses its patents, which cover a device that causes the heart's left and right ventricles to contract simultaneously when the heart beats, to Guidant Corporation, now a part of Boston Scientific.

Mirowski is represented by Arthur I. Neustadt, Thomas J. Fisher and John F. Presper of Oblon Spivak McClelland Maier & Neustadt LLP.

Please click on the  publication link to read the full article.